October 30,2007
Grassley delves further into FDA review of foreign-made pharmaceuticals
WASHINGTON — Sen. Chuck Grassley is following up on his initial inquiry of the Food and Drug Administration regarding its work to ensure the safety of foreign-made pharmaceutical ingredients and medicines with a series of questions about foreign inspection funding, FDA registration of foreign plants, newly emerging exporters of pharmaceuticals, and weaknesses in the foreign inspection process.
The text of the letter he sent today to the FDA Commissioner follows here, along with the text of his August letter.
###
Next Article Previous Article
Recent News
- Wyden, Warner, Merkley and Schumer Highlight Threat to Nursing Homes if GOP Approves Medicaid Cuts
- Wyden Statement on Tax-Related Parliamentarian Rulings
- Following Pressure From Wyden and Colleagues, Trump Administration Confirms No Frontline Workers Have Been Recategorized as “Schedule F” at Social Security
- Wyden Statement on Supreme Court Planned Parenthood Ruling
- Wyden, Merkley, Colleagues Demands Congressional Leaders Reverse Devastating Budget Cuts to Medicaid and the Affordable Care Act